Bvf Inc Cytokinetics Inc Transaction History

Bvf Inc

  • $3.15 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$18.57 - $25.68 $90.6 Million - $125 Million
-4,878,035 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$15.26 - $28.61 $23.7 Million - $44.5 Million
1,554,984 Added 46.79%
4,878,035 $101 Million
Q3 2020

Nov 13, 2020
BUY
$20.58 - $28.96 $68.4 Million - $96.2 Million
3,323,051 New
3,323,051 $71.9 Million
Q2 2020

Aug 14, 2020
SELL
$11.15 - $24.64 $43.9 Million - $97 Million
-3,938,280 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$8.75 - $16.3 $28.6 Million - $53.3 Million
-3,268,178 Reduced 45.35%
3,938,280 $46.4 Million
Q4 2019

Feb 14, 2020
BUY
$7.95 - $11.84 $24.2 Million - $36 Million
3,040,900 Added 73.0%
7,206,458 $76.5 Million
Q3 2019

Nov 14, 2019
SELL
$10.82 - $14.25 $10.9 Million - $14.4 Million
-1,011,320 Reduced 19.54%
4,165,558 $47.4 Million
Q2 2019

Aug 14, 2019
BUY
$7.95 - $11.25 $10.9 Million - $15.5 Million
1,375,061 Added 36.17%
5,176,878 $58.2 Million
Q1 2019

May 15, 2019
SELL
$5.95 - $10.19 $2.08 Million - $3.55 Million
-348,822 Reduced 8.4%
3,801,817 $30.8 Million
Q4 2018

Feb 14, 2019
SELL
$5.91 - $9.29 $6.12 Million - $9.63 Million
-1,036,200 Reduced 19.98%
4,150,639 $26.2 Million
Q3 2018

Nov 14, 2018
SELL
$6.4 - $9.85 $2.33 Million - $3.59 Million
-364,051 Reduced 6.56%
5,186,839 $51.1 Million
Q2 2018

Aug 14, 2018
SELL
$6.9 - $9.9 $1.18 Million - $1.69 Million
-170,998 Reduced 2.99%
5,550,890 $46.1 Million
Q4 2017

Feb 14, 2018
BUY
$7.25 - $15.65 $32.5 Million - $70.1 Million
4,480,867 Added 361.06%
5,721,888 $46.6 Million
Q3 2017

Nov 14, 2017
BUY
$12.0 - $15.0 $14.9 Million - $18.6 Million
1,241,021
1,241,021 $18 Million

Others Institutions Holding CYTK

# of Institutions
409
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.6B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email